Skip to main content
Clinical Trials/NCT06417177
NCT06417177
Recruiting
Early Phase 1

Impact of Early Aging and Menopause on the Vascular Responses to Hypoxia

University of Missouri-Columbia1 site in 1 country75 target enrollmentJune 3, 2024

Overview

Phase
Early Phase 1
Intervention
Propranolol
Conditions
Aging
Sponsor
University of Missouri-Columbia
Enrollment
75
Locations
1
Primary Endpoint
Forearm blood flow
Status
Recruiting
Last Updated
7 months ago

Overview

Brief Summary

The purpose of this study is to examine hypoxic vasodilation and the role of beta-adrenergic receptors in younger premenopausal, perimenopausal, and older postmenopausal women.

Registry
clinicaltrials.gov
Start Date
June 3, 2024
End Date
July 1, 2026
Last Updated
7 months ago
Study Type
Interventional
Study Design
Crossover
Sex
Female

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Jacqueline K Limberg, PhD

Associate Professor

University of Missouri-Columbia

Eligibility Criteria

Inclusion Criteria

  • Female assigned at birth
  • Pre, peri- or post-menopausal
  • Healthy weight (BMI ≥18 and ≤30 kg/m2)

Exclusion Criteria

  • Male (assigned at birth)
  • Pregnancy, breastfeeding
  • Use of hormone replacement therapies
  • Hysterectomy
  • Body mass index \>30 kg/m2
  • Diagnosed sleep apnea
  • Current smoking/Nicotine/Drug use
  • Nerve/neurologic disease
  • Cardiovascular, hepatic, renal, respiratory disease
  • Blood pressure ≥140/90 mmHg

Arms & Interventions

Cold pressor test

Participants will be exposed to the cold pressor test (ice water on the foot).

Intervention: Propranolol

Cold pressor test

Participants will be exposed to the cold pressor test (ice water on the foot).

Intervention: Placebo

Hypoxia

Participants will be exposed to hypoxia (low oxygen air) using a mask.

Intervention: Placebo

Hypoxia

Participants will be exposed to hypoxia (low oxygen air) using a mask.

Intervention: Propranolol

Hypoxia

Participants will be exposed to hypoxia (low oxygen air) using a mask.

Intervention: Gemtesa

Cold pressor test

Participants will be exposed to the cold pressor test (ice water on the foot).

Intervention: Gemtesa

Hypercapnia

Participants will be exposed to hypercapnia (high carbon dioxide air) using a mask.

Intervention: Placebo

Hypercapnia

Participants will be exposed to hypercapnia (high carbon dioxide air) using a mask.

Intervention: Propranolol

Hypercapnia

Participants will be exposed to hypercapnia (high carbon dioxide air) using a mask.

Intervention: Gemtesa

Outcomes

Primary Outcomes

Forearm blood flow

Time Frame: Change from baseline to 5 minutes.

Blood flow in the forearm measured with venous occlusion plethysmography.

Study Sites (1)

Loading locations...

Similar Trials